Sulawesi patient screening identifies known viruses in historical samples
A peer-reviewed study of 217 symptomatic patients in Indonesia’s North Sulawesi found screened viruses in 63 people. Samples collected in 2017–2018 contained known viral lineages, rather than a newly identified virus. Combining clinical tests with animal-contact questionnaires demonstrated a surveillance approach, but the small sample and restricted panel cannot establish which infections came from animals.
Science··Evening
Historical samples yield known viral lineages
A newly published, peer-reviewed investigation examined samples collected in 2017–2018 from 217 symptomatic patients in Minahasa, in Indonesia’s North Sulawesi region. A district hospital enrolled 109 patients and a primary health centre enrolled 108. At least one screened viral group was detected in 63 people, approximately 29 per cent. Sequencing linked the detections to previously characterized strains with 97–100 per cent identity. The publication concerns historical clinical surveillance, rather than a current outbreak or a newly discovered viral lineage.[1]
A nine-group panel identifies several infections
The team used polymerase chain reaction (PCR) screening for nine viral families or genera, then sequenced positive products. Detections included 21 influenza results, alongside 15 flavivirus detections and 14 pneumovirus detections. Known agents included dengue, rhinoviruses and respiratory syncytial virus, or RSV. Three patients had co-infections, so viral detections cannot simply be read as mutually exclusive patient groups. Negative henipavirus, hantavirus and filovirus panels do not establish that these agents were absent from wildlife or the wider population.[1]
Questionnaires documented animal contact and behaviour alongside clinical sampling. Associations between contact categories and positive PCR tests were not statistically significant, with wide uncertainty intervals. Reporting contact with an animal does not identify the origin of a patient’s infection. The small group consisted of healthcare attendees, preventing a general-population prevalence estimate. Serological testing and untargeted metagenomic sequencing were not performed. The authors propose larger, longer surveillance efforts to extend this combined clinical and animal-contact approach.[1]